ACCD Accolade Inc

USD 10.48 0.49 4.904905
Icon

Accolade Inc (ACCD) Stock Analysis and Price Targets

COMMON STOCK | Health Information Services | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 10.48

+0.49 (+4.90)%

USD 0.77B

0.70M

USD 14.67(+39.95%)

USD 13.44 (+28.24%)

Icon

ACCD

Accolade Inc (USD)
COMMON STOCK | NSD
USD 10.48
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.77B

USD 13.44 (+28.24%)

USD 10.48

Accolade Inc (ACCD) Stock Forecast

Show ratings and price targets of :
USD 14.67
(+39.95%)

Based on the Accolade Inc stock forecast from 11 analysts, the average analyst target price for Accolade Inc is USD 14.67 over the next 12 months. Accolade Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Accolade Inc is Bearish, which is based on 1 positive signals and 8 negative signals. At the last closing, Accolade Inc’s stock price was USD 10.48. Accolade Inc’s stock price has changed by +7.49% over the past week, -0.10% over the past month and -19.75% over the last year.

No recent analyst target price found for Accolade Inc
No recent average analyst rating found for Accolade Inc

Company Overview Accolade Inc

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company off...Read More

https://www.accolade.com

660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462

2,370

February

USD

USA

Adjusted Closing Price for Accolade Inc (ACCD)

Loading...

Unadjusted Closing Price for Accolade Inc (ACCD)

Loading...

Share Trading Volume for Accolade Inc Shares

Loading...

Compare Performance of Accolade Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ACCD

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Accolade Inc (Sector: Health Information Services )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
GEHC
GE HealthCare Technologies Inc.. +0.60 (+0.66%) USD42.33B 30.58 13.92

ETFs Containing ACCD

Symbol Name ACCD's Weight Expense Ratio Price(Change) Market Cap
FEM
First Trust Emerging Mark.. 1.25 % 0.80 % +0.04 (+0.18%) USD0.43B

Frequently Asked Questions About Accolade Inc (ACCD) Stock

Based on ratings from 11 analysts Accolade Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 10 buy, sell and 3 hold ratings.

Unfortunately we do not have enough data on ACCD's stock to indicate if its a good dividend stock.

Based on targets from 11 analysts, the average taret price for ACCD is USD 14.67 over the next 12 months. The maximum analyst target price is USD 17 while the minimum anlayst target price is USD 10.

ACCD stock's Price/Earning ratio is -99,999.99. Our analysis grades ACCD stock's Price / Earning ratio at A+. This means that ACCD stock's Price/Earning ratio is above 0% of the stocks in the Health Information Services sector in the NSD exchange. Based on this ACCD may be undervalued for its sector.

The last closing price of ACCD's stock was USD 10.48.

The most recent market capitalization for ACCD is USD 0.77B.

Based on targets from 11 analysts, the average taret price for ACCD is projected at USD 14.67 over the next 12 months. This means that ACCD's stock price may go up by +39.95% over the next 12 months.

Following are ETFs with the highest allocation to Accolade Inc's stock :

FEM

As per our most recent records Accolade Inc has 2,370 Employees.

Accolade Inc's registered address is 660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462. You can get more information about it from Accolade Inc's website at https://www.accolade.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...